Label Changes for:
Qualaquin (Quinine Sulfate) Capsules
April 2013
Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) –
April 2013
WARNINGS AND PRECAUTIONS
QT Prolongation and Ventricular Arrhythmias
- Qualaquin has been shown to cause concentration-dependent prolongation of the PR and QRS interval…
